(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ORGOVYX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

ORGOVYX

ST13

US500000090132142

Class

5

Filing

90132142

Registration

6338910

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

05/21/2026

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

08/24/2020

Registration date

05/04/2021

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/04/2021

Last transaction

05/21/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

99

Owner location

OSAKA, JP

Examiner

WOOD, CAROLINE

Law office

M10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

SUMITOMO PHARMA CO., LTD.
SUMITOMO PHARMA SWITZERLAND GMBH
Myovant Sciences GmbH

Representatives

Jeffrey R. Cadwell Dorsey & Whitney LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for human use for the treatment of oncological diseasesdisorders and conditionsprostate cancer; biologic preparations for medical and therapeutic purposes for the treatment of oncological diseasesdisorders and conditionsprostate cancer

Publications

History of USPTO decisions and trademark events.

25 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

05/20/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

05/04/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/15/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

05/15/2024

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

05/15/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/15/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/15/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/15/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/15/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

12/13/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/26/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/26/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/26/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/26/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/26/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

05/04/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/16/2021

PUBO

PUBLISHED FOR OPPOSITION

02/16/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/27/2021

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

12/30/2020

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

12/25/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/22/2020

DOCK

ASSIGNED TO EXAMINER

12/21/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/25/2020

NWAP

NEW APPLICATION ENTERED

08/27/2020

Continuous trademark protection

Get notified about every new filing that threatens ORGOVYX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.